Deconstructing nucleotide binding activity of the Mdm2 RING domain
Open Access
- 29 July 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 38 (21), 7587-7598
- https://doi.org/10.1093/nar/gkq669
Abstract
Mdm2, a central negative regulator of the p53 tumor suppressor, possesses a Really Interesting New Gene (RING) domain within its C-terminus. In addition to E3 ubiquitin ligase activity, the Mdm2 RING preferentially binds adenine base nucleotides, and such binding leads to a conformational change in the Mdm2 C-terminus. Here, we present further biochemical analysis of the nucleotide–Mdm2 interaction. We have found that MdmX, an Mdm2 family member with high sequence homology, binds adenine nucleotides with similar affinity and specificity as Mdm2, suggesting that residues involved in nucleotide binding may be conserved between the two proteins and adenosine triphosphate (ATP) binding may have similar functional consequences for both Mdm family members. By generating and testing a series of proteins with deletions and substitution mutations within the Mdm2 RING, we mapped the specific adenine nucleotide binding region of Mdm2 to residues 429–484, encompassing the minimal RING domain. Using a series of ATP derivatives, we demonstrate that phosphate coordination by the Mdm2 P-loop contributes to, but is not primarily responsible for, ATP binding. Additionally, we have identified the 2′ and 3′ hydroxyls of the ribose and the C6 amino group of the adenine base moiety as being essential for binding.This publication has 57 references indexed in Scilit:
- The p53 orchestra: Mdm2 and Mdmx set the toneTrends in Cell Biology, 2010
- The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppressionOncogene, 2009
- A Function for the RING Finger Domain in the Allosteric Control of MDM2 Conformation and ActivityOnline Journal of Public Health Informatics, 2009
- Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative DiseasesMolecules, 2009
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?Molecular Cancer Research, 2009
- Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysisBiochemical Journal, 2007
- Cancer-Associated Mutations in the MDM2 Zinc Finger Domain Disrupt Ribosomal Protein Interaction and Attenuate MDM2-Induced p53 DegradationMolecular and Cellular Biology, 2007
- An essential function of the extreme C-terminus of MDM2 can be provided by MDMXThe EMBO Journal, 2006
- The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activityThe EMBO Journal, 2006
- Mdmx as an essential regulator of p53 activityBiochemical and Biophysical Research Communications, 2005